Please select the option that best describes you:
How do you approach post-operative SRS for resected brain metastases in the presence of residual disease?
Do you ever boost the areas of residual tumor or do you treat the cavity and tumor as a homogeneous target volume?
Answer from: Radiation Oncologist at Academic Institution
I try to dose-escalate to gross disease, based on first principles. Of course, there is not exactly a standard dose and fractionation for SRS/SRT, so judgment is in play for each case based on size, location, and maybe histology. Still, homogeneity is not a priority for SRS, and it makes sense to pu...
Sign in or Register to read more